Click here to create your personal news page. The news that appears on Carol Nacy will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.  

topics : related - allExplore

Shopping Categories

  1. 1. Digital Camera
  2. 2. LCD Monitor
  3. 3. Mobile Phone
  4. 4. LCD TV
  5. 5. Laptop Computer
  6. 6. Graphic Card
  7. 7. Smartphone
  8. 8. Fridge
  9. 9. Freezer
  10. 10. Vacuum Cleaner
  11. 11. Digital Camcorder
  12. 12. Processor
  13. 13. Washing Machine
  14. 14. Microwave
  15. 15. Coffee Maker & Expresso

Wikio Shopping

  1. 1. Baby & Nursery
  2. 2. Car/Motor Bike
  3. 3. Communication
  4. 4. Computers
  5. 5. Electronics
  6. 6. Entertainment
  7. 7. Fashion & Lingerie
  8. 8. Finance
  9. 9. Gifts & Gadgets
  10. 10. Health & Beauty
  11. 11. Home & Garden
  12. 12. Household Appliances
  13. 13. Sport & Fitness
  14. 14. Travel
  15. 15. Video Games

Participate

News Categories



Carol Nacy



Sort by : relevance - date
+Vote!

Sequella Presents Data On Synergy Between Investigational New TB Drugs SQ109 And TMC207

Medical News Today (Free subscription) | 29/10/2008

... potent, with greater than 90% kill of MTB as early as 1 day after drug combination exposure.Dr. Carol Nacy, CEO of Sequella said, "We are very pleased to be collaborating with Tibotec, a world renowned product development organization, and we look forward to our continuing partnership to examine these important drug synergies in animal models of TB."The next step of the collaboration...

+Vote!

Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207

PR News Wire (Free subscription) | 28/10/2008

... potent, with greater than 90% kill of MTB as early as 1 day after drug combination exposure. Dr. Carol Nacy, CEO of Sequella said, "We are very pleased to be collaborating with Tibotec, a world renowned product development organization, and we look forward to our continuing partnership to examine these important drug synergies in animal models of TB." The next step of the collaboration...